Key facts
- Genee Technology’s last known valuation is $27.3M (Jan 2025).
- It has raised $6.2M; the latest was Later Stage VC ($1.4M) in Jan 2025.
- Notable investors include Anpel Laboratory Technologies, Shanghai Caitong Asset Management, Shenze Venture Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Genee Technology
- ·The full record, as it builds
Funding rounds
No funding rounds for Genee Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Genee Technology
Provider and operator of scientific research service intended to serve the platform. The company is mainly focused on the research and development of the technological service platform, providing clients with one-stop highly customized service.
- Sector
- Information Technology
- HQ
- Tianjin, China
- Founded
- 2008
- Employees
- 114
- Website
- geneegroup.com/
- Ownership
- Privately Held (backing)
Genee Technology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Genee Technology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Genee Technology in its N-PORT filings yet. We sweep new filings monthly.